Compounds > cholecystokinin (27-33)
Page last updated: 2024-09-03

cholecystokinin (27-33) and cholecystokinin pentapeptide

cholecystokinin (27-33) has been researched along with cholecystokinin pentapeptide in 1 studies

Compound Research Comparison

Studies
(cholecystokinin (27-33))		Trials
(cholecystokinin (27-33))		Recent Studies (post-2010)
(cholecystokinin (27-33))		Studies
(cholecystokinin pentapeptide)		Trials
(cholecystokinin pentapeptide)		Recent Studies (post-2010) (cholecystokinin pentapeptide)
39001010

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Camus, A; Rose, C; Schwartz, JC1

Other Studies

1 other study(ies) available for cholecystokinin (27-33) and cholecystokinin pentapeptide

ArticleYear
A serine peptidase responsible for the inactivation of endogenous cholecystokinin in brain.
    Proceedings of the National Academy of Sciences of the United States of America, 1988, Volume: 85, Issue:21

    Topics: Animals; Cerebral Cortex; Cholecystokinin; Chromatography, High Pressure Liquid; Peptide Fragments; Rats; Serine Endopeptidases; Serine Proteinase Inhibitors; Sincalide

1988